Drug Type Diagnostic radiopharmaceuticals |
Synonyms- |
Target- |
Action enhancers |
Mechanism PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingClinical |
First Approval Date- |
Regulation- |
Molecular FormulaC3H7NO2 |
InChIKeyFSYKKLYZXJSNPZ-BJUDXGSMSA-N |
CAS Registry2043948-41-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Prostatic Cancer | Clinical | United States | 01 Jun 2015 |





